Last close As at 05/08/2026
—
— 0.00 (0.00%)
Market capitalisation
—
Research: TMT
EMIS reported H123 revenue and adjusted operating profit in line with board expectations. Revenue grew 2% year-on-year and adjusted operating profit was 7% higher, with an adjusted operating margin of 26.9% (+120bp y-o-y). The company closed H123 with net cash of £48.5m. Assuming the takeover of EMIS is not effective prior to 7 October, on 23 October the company will pay an interim dividend of 21.3p to shareholders on the register on 6 October.
EMIS Group |
H123 on track; 21.3p interim dividend declared |
H123 results |
Software and comp services |
8 September 2023 |
Share price performance
Business description
Analyst
For the purposes of the Takeover Code, Edison Investment Research is deemed to be connected with EMIS Group. EMIS Group is a research client of Edison Investment Research Limited |
||||||||||||||||||||||||||||||||||||
EMIS reported H123 revenue and adjusted operating profit in line with board expectations. Revenue grew 2% year-on-year and adjusted operating profit was 7% higher, with an adjusted operating margin of 26.9% (+120bp y-o-y). The company closed H123 with net cash of £48.5m. Assuming the takeover of EMIS is not effective prior to 7 October, on 23 October the company will pay an interim dividend of 21.3p to shareholders on the register on 6 October.
Year end |
Revenue |
PBT* |
Diluted EPS* (p) |
EMIS adjusted diluted EPS** (p) |
DPS |
P/E |
12/19 |
159.5 |
41.0 |
53.5 |
51.1 |
31.2 |
35.9 |
12/20 |
159.5 |
43.4 |
56.4 |
50.4 |
32.0 |
34.1 |
12/21 |
168.2 |
43.5 |
55.0 |
55.5 |
35.2 |
34.9 |
12/22 |
175.4 |
48.1 |
60.9 |
61.2 |
38.7 |
31.6 |
Note: *PBT and EPS are normalised, excluding amortisation of acquired intangibles, exceptional items and share-based payments. **EMIS adjusted EPS – cash accounts for development costs and excludes exceptional items and amortisation of acquired intangibles.
EMIS reported H123 revenue of £88.8m (+2% y-o-y) and recurring revenue of £76.0m (+6% y-o-y). Adjusted operating profit of £23.9m was 7% higher y-o-y. EMIS Health reported revenue of £52.8m (+3% y-o-y) including a £1.9m contribution from Healthcare Gateway, which was acquired in H222. Adjusted operating profit of £14.0m (+12% y-o-y) benefited from tight cost control and a better revenue mix. EMIS Enterprise reported revenue of £36.0m (flat y-o-y) and adjusted operating profit of £10.8m (+1% y-o-y), with growth in analytics offsetting one-off revenues from Pinnacle and Partners in H122. Reported operating profit of £12.7m included one-off costs of £8.4m (£3.1m in transaction costs for the takeover and £5.3m for the ongoing technology transformation programme). EMIS announced an interim dividend of 21.3p, payable on 23 October to shareholders on the register on 6 October, assuming the deal has not become effective prior to 7 October. This will be paid without any reduction in the acquisition cash consideration of 1,925p per EMIS share. As a reminder, on 11 August the Competition and Markets Authority (CMA) gave provisional approval to the takeover of EMIS by UnitedHealth. The deadline for the public consultation period was 1 September and the CMA’s final report is due by 5 October, after which EMIS expects to provide a further update.
|
|
Research: Industrials
Severfield’s AGM statement highlights that FY24 is expected be in line with management expectations and that the quality of the orderbooks – both in the UK and Europe, and India – remains a key support for the future. That said, the outlook for the UK and continental Europe is less robust in the short term than it was due to the impact of high inflation and the rising interest rate cycle. The FY24e P/E rating of c 7x remains comfortably below the long-term average of 10.0x, implying that some risk is discounted in the rating. The stock yields more than 5%.